GSK Egypt announces EGP 250.5M exceptional dividends
GlaxoSmithKline (GSK – Egypt) (EGX:BIOC) announced exceptional dividends of EGP 250.543 million, or EGP 3 per share, for the period ended in April 2022, according to a filing to the Egyptian Exchange (EGX) on Wednesday.